TokenPost·
Allogene Targets Year-End 2027 Enrollment in ALPHA3 Study
The company plans a clinical update around midyear, with interim analysis and any unblinding under DSMB oversight.
More news
- TokenPostInjective Marks Canary Funds’ INJC ETF at Nasdaq Opening Bell
- TokenPostShinkin Joint Center Outage Leaves Customers of 128 Credit Unions Unable to Withdraw Cash
- TokenPostTrump Names Stephen Miller as White House Chief of Staff
- Crypto BriefingWeb3Auth pauses embedded wallet service after security issue, Keplr users hit
- TokenPostPepe Breaks Above Long-Term Descending Trendline
- TokenPostDogeGod Claims Large Holders Acquired 130 Million DOGE in Two Days